Showing results (61-70 of 148) with videos related to
Sort By:
Pageof 15
British Journal of Rheumatology|August 1, 1989
A study of tolerance to the psychomotor effects of indomethacin in healthy volunteersT Pullar, S Dale, J Lowe, et al.Annals of the Rheumatic Diseases|June 1, 1992
Double blind, placebo controlled study of metronidazole as a disease modifying agent in the treatment of rheumatoid arthritisD A Marshall, J A Hunter, H A CapellClinical Rheumatology|November 26, 2002
The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-upA W Al-Allaf, L Ottewell, T PullarClinical Pharmacology and Therapeutics|August 1, 1989
Time to stop counting the tablets?T Pullar, S Kumar, H Tindall, et al.Journal of Clinical Pharmacy and Therapeutics|August 1, 1990
Patterns of out-patients non-steroidal anti-inflammatory drug prescribing in two teaching hospital rheumatology units--implications for post-marketing surveillanceT Pullar, B Murphy, A Taggart, et al.The Journal of Rheumatology|November 1, 1996
Sulfasalazine has a better efficacy/toxicity profile than auranofin--evidence from a 5 year prospective, randomized trialA McEntegart, D Porter, H A Capell, et al.Annals of the Rheumatic Diseases|December 1, 1994
Outcome of second line therapy in rheumatoid arthritisD R Porter, I McInnes, J Hunter, et al.Rheumatology (Oxford, England)|July 4, 2002
Illiteracy in rheumatoid arthritis patients as determined by the Rapid Estimate of Adult Literacy in Medicine (REALM) scoreM-M Gordon, R Hampson, H A Capell, et al.Annals of the Rheumatic Diseases|April 1, 1992
Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritisD Porter, R Madhok, J A Hunter, et al.Annals of the Rheumatic Diseases|May 1, 1990
Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritisM Brzeski, R Madhok, J A Hunter, et al.Pageof 15